Form D · Other Health Care

Nfocus Neuromedical, Inc.

Palo Alto, CA · CIK 0001394941

Offering snapshot reported Apr 12, 2011 · SEC filing

Reported sold: $7.54M
Investors reported: 11
Minimum accepted: $0
First sale: Jul 8, 2010

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$3,314,652 → $7,542,266
Reported investors6 → 11

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Apr 12, 2011	Amendment	$7,542,266	$4,227,614vs Jul 22, 2010	11	SEC filing
Jul 22, 2010	Initial	$3,314,652	No comparison	6	SEC filing
Jul 1, 2009	Initial	$7,666,430	No comparison	8	SEC filing
Mar 27, 2007	Paper	Not reported	No comparison	Not reported	SEC filing

Offering details

Securities: Equity
Exemptions: 06
Duration over one year: No
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-145323

Source: Form D, filed Apr 12, 2011. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Omar Amirana	Director
Omar Amirana, M.D.	Director
Martin Dieck	Director, Executive
Mir A. Imran	Director
Eric Milledge	Director
Jill Papp	Executive
Roger J. Quy	Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:

2191 E. Bayshore Road Suite 100
Palo Alto, CA, 94303